We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$63.4B
AUM Growth
+$7.19B
Cap. Flow
+$2.26B
Cap. Flow %
3.57%
Top 10 Hldgs %
20.45%
Holding
3,416
New
220
Increased
1,562
Reduced
1,192
Closed
117

Top Buys

Rank Stock Value
1
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$245M
2
MSFT icon
Microsoft
MSFT
+$173M
3
AMZN icon
Amazon
AMZN
+$155M
4
NVDA icon
NVIDIA
NVDA
+$133M
5
AAPL icon
Apple
AAPL
+$93.5M

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$96.9M
2
CAE icon
CAE Inc. Common Shares
CAE
+$67.7M
3
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
+$64.3M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$53M
5
DELL icon
Dell
DELL
+$51.1M

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Financials 12.98%
3 Healthcare 11.43%
4 Consumer Discretionary 10.44%
5 Real Estate 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CIFR icon
3176
Cipher Digital
CIFR
$7.14B
$227 ﹤0.01%
+44
New +$152
BCBP icon
3177
BCB Bancorp
BCBP
$158M
$219 ﹤0.01%
21
-337
-94% -$3.85K
MLYS icon
3178
Mineralys Therapeutics
MLYS
$2.41B
$219 ﹤0.01%
17
-5,762
-100% -$71.2K
SVRN
3179
OceanPal Inc
SVRN
$12.1M
– –
0
– –
WULF icon
3180
TeraWulf
WULF
$8.36B
$213 ﹤0.01%
+81
New +$160
LICY
3181
DELISTED
Li-Cycle Holdings Corp.
LICY
$212 ﹤0.01%
+26
New +$117
ELVN icon
3182
Enliven Therapeutics
ELVN
$4.31B
$211 ﹤0.01%
12
– –
ARQT icon
3183
Arcutis Biotherapeutics
ARQT
$3.3B
$208 ﹤0.01%
+21
New +$157
JBIO
3184
Jade Biosciences
JBIO
$1.36B
– –
0
– –
OVLY icon
3185
Oak Valley Bancorp
OVLY
$281M
$198 ﹤0.01%
8
-10
-56% -$255
RCUS icon
3186
Arcus Biosciences
RCUS
$3.66B
$189 ﹤0.01%
10
-15,865
-100% -$274K
BCML icon
3187
BayCom
BCML
$341M
$185 ﹤0.01%
9
– –
OKUR
3188
OnKure Therapeutics
OKUR
$166M
$183 ﹤0.01%
+11
New +$181
EGAN icon
3189
eGain
EGAN
$203M
$181 ﹤0.01%
+28
New +$192
LFVN icon
3190
LifeVantage
LFVN
$84M
$175 ﹤0.01%
+29
New +$183
DVAX
3191
DELISTED
Dynavax Technologies
DVAX
$174 ﹤0.01%
14
-194
-93% -$2.53K
GCBC icon
3192
Greene County Bancorp
GCBC
$593M
$173 ﹤0.01%
6
– –
ACVA icon
3193
ACV Auctions
ACVA
$1.27B
$169 ﹤0.01%
9
-83
-90% -$1.3K
NXDR
3194
Nextdoor Holdings
NXDR
$1.03B
$160 ﹤0.01%
71
– –
AKYA
3195
DELISTED
Akoya BioSciences
AKYA
$159 ﹤0.01%
+34
New +$177
BY icon
3196
Byline Bancorp
BY
$1.76B
$152 ﹤0.01%
7
-99,311
-100% -$2.14M
RNAC icon
3197
Cartesian Therapeutics
RNAC
$260M
$137 ﹤0.01%
7
– –
HFFG icon
3198
HF Foods Group
HFFG
$95.2M
$130 ﹤0.01%
37
-218,757
-100% -$957K
TRDA icon
3199
Entrada Therapeutics
TRDA
$274M
$128 ﹤0.01%
9
– –
VALU icon
3200
Value Line
VALU
$375M
$122 ﹤0.01%
3
– –
126 127
128
129 130

Similar funds

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Russell Investments Group's Q1 2024 Portfolio in Review

As of Q1 2024, Russell Investments Group held 3,416 positions worth $63.4B, up 13% from $56.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Russell Investments Group deployed $2.26B of net new capital in Q1 2024, opening 220 new positions and adding to 1,562 existing holdings. Its largest new stake was American Healthcare REIT: 1,381,759 shares worth $20.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was SLB Ltd, an estimated $96.9M trimmed.

  • Russell Investments Group's largest Q1 2024 buy was American Healthcare REIT: 1,381,759 shares worth $20.4M.
  • Russell Investments Group added most to Bank of America Series L in Q1 2024, an estimated $245M increase.
  • Russell Investments Group's biggest Q1 2024 reduction was SLB Ltd, cutting an estimated $96.9M.
  • Russell Investments Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $64.3M.
  • Russell Investments Group's ten largest holdings make up 20% of its $63.4B portfolio in Q1 2024.
  • Russell Investments Group opened 220 new positions and closed 117 in Q1 2024.
  • Russell Investments Group's portfolio value rose 13% quarter-over-quarter to $63.4B.

Based on Russell Investments Group's 13F filing for Q1 2024, filed 8 May 2024.